{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":42,"n_cols":5,"rows_kept":42,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[14,2,14,3],[15,2,15,3],[19,2,19,3],[29,2,29,3],[29,4,29,5],[30,2,30,3],[30,4,30,5],[31,2,31,3],[31,4,31,5],[32,2,32,3],[33,2,33,3],[34,2,34,3],[35,2,35,3],[37,2,37,3],[38,2,38,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910958372903321"]
[null,null,"Autore",null,"Dark Graham"]
[null,null,"Titolo",null,"Oncology at a glance / / Graham G. Dark"]
[null,null,"Pubbl/distr/stampa",null,"Chichester, West Sussex, U.K., : Wiley-Blackwell, 2013"]
[{"$nulls":4},"Chichester, West Sussex : , : John Wiley & Sons, , 2013"]
[null,null,"ISBN",null,"9781118369708"]
[{"$nulls":4},"111836970X"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (132 pages) : illustrations"]
[null,null,"Collana",null,"At a glance"]
[null,null,"Disciplina",null,"616.99/4"]
[null,null,"Soggetti",null,"Oncology - Methodology"]
[{"$nulls":4},"Tumors - Diagnosis"]
[{"$nulls":4},"Tumors - Treatment"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Includes index."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Cover -- Title page -- Copyright page -- Contents -- Contributors -- Preface -- Abbreviations -- 1: The global burden of cancer -- The global burden of cancer -- Developed and developing countries -- Tobacco -- Lifestyle -- Infections -- Challenges -- 2: The nomenclature of oncology -- Tumour nomenclature -- Tumour grade -- Cytology -- Cytogenetic analysis -- Tumour stage -- Performance status -- 3: Environmental determinants of cancer -- Environmental factors -- Radiation -- Chemicals -- Smoking -- Infections -- Hormones -- Nutrition and lifestyle -- 4: The hallmarks of cancer I -- The 10 hallmarks of cancer -- 1. Genome instability and mutation -- 2. Resisting cell death -- 5: The hallmarks of cancer II -- 3. Sustaining proliferative signalling -- The cell cycle -- Cell cycle regulation -- Stimulation of the cell cycle -- 4. Evading growth suppressors -- 5. Enabling replicative immortality -- 6: The hallmarks of cancer III -- 6. Inducing angiogenesis -- 7. Activating invasion and metastasis -- 7: The hallmarks of cancer IV -- 8. Reprogramming energy metabolism -- 9. Tumour-promoting inflammation -- 10. Evading immune destruction -- 8: Cancer genetics and inherited cancer -- Principles of cancer genetics -- How genes cause cancer -- Oncogenes -- Tumour suppressor genes -- Multistep carcinogenesis -- Inherited cancer syndromes -- Autosomal dominant cancer syndromes -- Autosomal recessive cancer syndromes -- 9: Communicating with cancer patients -- Communicating with cancer patients -- The doctor-patient "]
[{"$nulls":4},"relationship -- Breaking bad news -- Steps to breaking bad news -- Dealing with the emotional patient -- Communicating with younger patients -- 10: Presenting problems in a patient with cancer -- Presenting features of cancer -- General features on examination -- Local effects -- Change of function -- Obstruction of a conduit -- Metastatic effects."]
[{"$nulls":4},"11: Paraneoplastic syndromes -- Ectopic hormone production -- Neurological manifestations -- Cutaneous manifestations -- Haematological manifestations -- Gastrointestinal manifestations -- Renal manifestations -- Other paraneoplastic syndromes -- 12: Metabolic emergencies in cancer patients -- Hypercalcaemia -- Syndrome of inappropriate antidiuresis -- Hypomagnesaemia -- Tumour lysis syndrome -- 13: Oncological emergencies -- Neutropenic sepsis -- Superior vena cava obstruction -- Spinal cord compression -- 14: Investigation and management of metastatic disease -- Brain metastases -- Lung metastases -- Liver metastases -- Bone metastases -- Malignant pleural effusion -- Malignant ascites -- Other sites -- 15: Tumour markers -- Serum proteins -- Clinical usefulness -- Human chorionic gonadotrophin -- Alpha-fetoprotein -- Placental alkaline phosphatase -- CA19-9 -- Inhibin -- Carcinoembryonic antigen (CEA) -- CA15-3 -- CA125 -- Squamous cell carcinoma-associated antigen (SCC) -- Prostate-specific antigen (PSA) -- Hormones -- 16: Screening for cancer -- Successful screening -- Lead time bias -- Length time bias -- Breast cancer screening -- Colorectal cancer screening -- Gastric cancer screening -- Prostate cancer screening -- Cervical cancer screening -- Ovarian cancer screening -- Lung cancer screening -- The future -- 17: Imaging in oncology -- Plain film imaging -- Ultrasound -- Computerised tomography -- Magnetic resonance imaging -- Radioisotope imaging -- Positron emission tomography -- 18: Approach to treatment and response assessment -- Treatment goals -- Treatment approach -- Assessment of toxicity -- Evaluation of treatment -- 19: Principles of surgical oncology -- Surgical oncology -- Prevention -- Evaluation of primary disease -- Biopsy types -- Staging -- Treatment -- Palliative procedures -- 20: Pharmacology of anticancer agents."]
[{"$nulls":4},"An introduction to chemotherapy -- Growth fractions and doubling time -- Tumour growth -- Drug resistance -- Class of chemotherapy agents -- 21: Principles of radiotherapy -- How radiotherapy works -- High-energy photons -- Photoelectric effect -- Compton effect -- Pair production -- Types of radiation treatment -- Electron beams -- Brachytherapy -- Conformal radiation therapy -- Intensity-modulated radiation therapy (IMRT) -- Proton therapy -- Stereotactic radiosurgery -- 22: Adverse effects of treatment -- Treatment toxicity -- Extravasation injury -- Specific toxicities -- Late adverse effects -- 23: Management of nausea -- Pathophysiology -- Oncology practice -- Approach to treatment -- Patients with advanced disease -- 24: Analgesia -- Pain assessment -- Treatment -- Opioid analgesia -- Side effects -- 25: Clinical trials in cancer patients -- Asking a research question -- Observational studies -- Phase I clinical trials -- Phase II clinical trials -- Phase III clinical trials -- Randomisation -- Meta-analysis -- 26: The role of multidisciplinary teams -- Multidisciplinary team meetings -- Role of the team -- Benefit of MDT meetings -- Combined clinics -- Recruitment into clinical trials -- Education opportunities -- 27: End of life care -- Physical symptoms -- Psychological issues -- Managing the terminal phase -- 28: Carcinoma of unknown primary -- Epidemiology -- Aetiology -- Clinical presentation -- Investigations and staging -- Initial investigations -- Treatment -- Prognosis -- 29: Breast cancer -- Epidemiology -- "]
[{"$nulls":4},"Aetiology and pathophysiology -- Clinical presentation -- Treatment -- Prevention -- Screening -- 30: Lung cancer -- Epidemiology -- Aetiology -- Pathophysiology -- Clinical presentation -- Investigations and staging -- Treatment -- 31: Mesothelioma -- Epidemiology -- Aetiology -- Clinical presentation."]
[{"$nulls":4},"Investigations and staging -- Treatment -- Prognosis -- 32: Oesophageal cancer -- Epidemiology -- Aetiology and pathophysiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- 33: Gastric cancer -- Epidemiology -- Aetiology -- Pathophysiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- 34: Colorectal cancer -- Epidemiology -- Aetiology -- Pathophysiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- Screening -- 35: Pancreatic cancer -- Epidemiology -- Aetiology -- Clinical presentation -- Investigations and staging -- Staging -- Treatment -- Prognosis -- 36: Hepatobiliary cancer -- Epidemiology -- Aetiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- 37: Ovarian cancer -- Epidemiology -- Aetiology -- Pathophysiology -- Clinical presentation -- Investigation and staging -- Treatment -- Complications -- Prognosis -- 38: Endometrial cancer -- Epidemiology -- Aetiology -- Clinical presentation -- Investigations and staging -- Treatment -- Complications -- Prognosis -- 39: Cervical cancer -- Epidemiology -- Aetiology -- Clinical presentation -- Investigations and staging -- Screening -- Screening following treatment -- Treatment -- Prognosis -- 40: Germ cell tumours -- Epidemiology -- Aetiology -- Pathophysiology -- Seminoma and dysgerminoma -- Non-seminoma -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- 41: Prostate cancer -- Epidemiology -- Aetiology and pathophysiology -- Clinical presentation -- Investigations and staging -- Treatment -- Screening -- Prognosis -- 42: Bladder and renal cancer -- Aetiology -- Pathophysiology -- Clinical presentation -- Investigations and staging -- Treatment -- Bladder cancer -- Renal cancer -- Prognosis -- 43: Head and neck cancer."]
[{"$nulls":4},"Epidemiology -- Aetiology -- Pathophysiology -- Clinical examination -- Investigations and staging -- Treatment -- Prognosis -- 44: Thyroid cancer -- Epidemiology -- Aetiology -- Pathophysiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- 45: Bone cancer and sarcoma -- Epidemiology -- Aetiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- 46: Skin cancer -- Epidemiology -- Aetiology -- Non-melanoma skin cancer -- Basal cell carcinoma -- Squamous cell carcinoma -- Melanoma -- 47: Cancers of the central nervous system -- Epidemiology -- Aetiology -- Clinical presentation -- Glial tumours -- Meningioma -- Spinal axis tumours -- Investigations and staging -- Treatment -- Complications -- Prognosis -- 48: Neuroendocrine tumours -- Argentaffin and hormone secretion -- Carcinoid tumours -- Gastroenteropancreatic NETs -- Insulinoma -- Gastrinoma -- Glucagonoma -- VIPoma -- Somatostatinoma -- Phaeochromocytoma -- Serum tumour markers -- 49: Leukaemia -- Epidemiology and pathogenesis -- Clinical presentation -- Investigations and classification -- Treatment -- Prognosis -- 50: Hodgkin's lymphoma -- Epidemiology -- Aetiology -- Pathophysiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- 51: Non-Hodgkin's lymphoma -- Epidemiology -- Aetiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis -- 52: Myeloma -- Epidemiology -- Aetiology -- Clinical presentation -- Investigations and staging -- Treatment -- Prognosis "]
[{"$nulls":4},"-- 53: Childhood cancers -- Paediatric oncology -- Teenager and young adult oncology -- Aetiology -- Haematological cancers -- Leukaemia -- Lymphoma -- Embryonal tumours -- Neuroblastoma -- Retinoblastoma -- Nephroblastoma (Wilm's tumour) -- Hepatoblastoma -- Central nervous system cancer -- Glioma."]
[{"$nulls":4},"Intracranial and intraspinal embryonal tumours."]
[null,null,null,"Sommario/riassunto","This brand new title in the market-leading at a Glance series brings together fundamental information on cancer biology and treatment to provide a holistic understanding of oncology. It explores both relevant scientific content and key human issues, including communication and palliative care. Oncology at a Glance:  Provides an accessible overview of the scientific foundation of cancer medicine  Covers the common cancers as well as key information on presentation and approaches to investigation and management  Includes young adult oncology, the multidisciplinary team, clinical trials in oncology, approach to treatment and response assessment, management of nausea, and end-of-life care  Was developed with students for students, to ensure it contains exactly what students need to know Oncology at a Glance is an ideal guide for medical students and foundation-year doctors as well as any other healthcare professionals looking to consolidate their knowledge of oncology."]
[null,"2.","Record Nr.",null,"UNINA9910157758403321"]
[null,null,"Autore",null,"Tipton A. J."]
[null,null,"Titolo",null,"Transformateurs d'ours Milliardaires"]
[null,null,"Pubbl/distr/stampa",null,"AJ Tipton Enterprises, LLC"]
[null,null,"ISBN",null,"1-5071-6005-4"]
[null,null,"Descrizione fisica",null,"1 online resource (189 p.)"]
[null,null,"Soggetti",null,"Paranormal romance stories"]
[{"$nulls":4},"Fantasy literature"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Sommario/riassunto","Les ours milliardaires combattent pour leurs vrais compagnons.Cette série pleine d'actions où figurant des hommes forts, des femmes confiantes, et des scènes d'amour fumeuses dans un monde magique, multidimensionnel qui émoustillent les sens.L'héritier alpha: Orson s'est mis en marche avec détermination. Casey veut simplement cuisiner des mets incroyables. Lorsque leurs chemins entre en collision, l'effet est délicieux. Cette nouvelle comprend une cuisine à faire saliver d'envie, des batailles de transformateurs atroces, et un amour si chaud qu'il craque.Les compagnons de l'alpha: Cléo est un alpha et Directrice d'exploitation opérationnelle de sa propre très grande entreprise à succès. Titus et Connor possède un ranch, un sanctuaire pour les créatures surnaturelles. Lorsque Cléo est bloquée dans leurs ranchs, des étincelles volent littéralement. Ce roman torride pour des lecteurs mûrs implique littéralement se rouler dans le foin, mouillée et sauvage lutte contre l'incendie, et un amour magique à la puissance trois.Le domaine de l'alpha: Sally a simplement découvert qu'elle est une sorcière. Ben essaie de se venger de l'assassinat de son clan. Est-ce que ces deux êtres seront trop distraits pour remarquer qu'ils sont entrain de tomber amoureux? Le roman paranormal pour adultes comprend des transformatrices sexy, de la magie explosive, et un amour sur un lieu de travail si chaud qu'il va même faire fondre les coeurs les plus froids.La flamme de Noël pour l'alpha: Dean est un pompier qui n'a pas de chance. Donna est une milliardaire brillante qui essaie de se le prouver. Leurs aventures vers l'amour comprennent des fées valeureuses, un poker déshabillé assumé, et une romance suivant "]
[{"$nulls":4},"la lutte contre un incendie si intense qui est trop chaud pour le manipuler.Situé dans le même monde comme la série d'AJ Tipton' \"Sa Viking é"]